Home / health news / Yahoo : declared in Trump chooses Gottlieb to run FDA; Pharma breathes sigh of relief
alibaba.com, cpa campaign, lead generation, lead campaign, smart match lander, intelligent lander, a

Yahoo : declared in Trump chooses Gottlieb to run FDA; Pharma breathes sigh of relief

as mentioned in Dr. Michael Carome, director of Public Citizen’s Health Research Group, said Gottlieb “has spent most of his career dedicated to promoting the financial interests of the pharmaceutical industry.”
Dr. Scott Gottlieb is seen in this American Enterprise Institute photo released in Washington, DC, U.S., March 10, 2017.
“Thank God it’s Gottlieb,” Brian Skorney, an investment analyst at Robert W. Baird, wrote in a research note.
He sits on the boards of several small drug and biotech companies and is an adviser to GlaxoSmithKline Plc .
He is a former FDA deputy commissioner who has advocated a loosening of requirements needed for approval of new medical products.

As it stated in

Trump chooses Gottlieb to run FDA; Pharma breathes sigh of relief

“Gottlieb is someone who the industry and investors view as an incremental positive,” said RBC Capital Markets analyst Michael Yee.
“The industry and investors need rational scientific logic and an understanding of risks and benefits.”Patient advocates welcomed the news.
“Thank God it’s Gottlieb,” Brian Skorney, an investment analyst at Robert W. Baird, wrote in a research note.
He sits on the boards of several small drug and biotech companies and is an adviser to GlaxoSmithKline Plc .
Gottlieb is well known on Capitol Hill, where he has testified multiple times on hot-button health issues, including complex drug pricing matters, and is viewed favorably by drug companies and pharmaceutical investors.

Trump chooses Gottlieb to run FDA; Pharma breathes sigh of relief

As it stated in Dr. Michael Carome, director of Public Citizen’s Health Research Group, said Gottlieb “has spent most of his career dedicated to promoting the financial interests of the pharmaceutical industry.”
“Gottlieb is someone who the industry and investors view as an incremental positive,” said RBC Capital Markets analyst Michael Yee.
Dr. Scott Gottlieb is seen in this American Enterprise Institute photo released in Washington, DC, U.S., March 10, 2017.
“Thank God it’s Gottlieb,” Brian Skorney, an investment analyst at Robert W. Baird, wrote in a research note.
He sits on the boards of several small drug and biotech companies and is an adviser to GlaxoSmithKline Plc (GSK.L).

This content may collect you by Luaren Colin

To follow all the new news about health

Check Also

picture.jpg

A new recommendation to reduce the number of shots for children of HPV vaccine

according to “This vaccine should have been introduced as a vaccine that will prevent cancer, …